Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Miranda Jayne Toledano is Director at Journey Medical. OQRO lists 2 transactions filed with the SEC under this name, the latest on Jul 2, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
Miranda Jayne Toledano bought shares on the open market in 2021, 2022 and 2023, and has not bought since 2023 across 2 companies.
Miranda Jayne Toledano reported 5 open-market purchases and 0 sales since 2021; purchases in 3 different years, most recently 2023.
| Year | Bought | Sold |
|---|---|---|
| 2023 | $47K2×2 trades | — |
| 2022 | $45K2×2 trades | — |
| 2021 | $10K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Journey MedicalDERM
2 disclosures · Jun 2026 – Jul 2026
Jul 1, 202650Kdisclosed Jul 2
DetailsOfficial recordJun 25, 202610Kdisclosed Jun 29
DetailsOfficial recordAs of the latest filing on , Miranda Jayne Toledano reported holding 168,618 shares of Journey Medical (DERM), worth about $624K at the last close of $4 (Nov 16, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Journey Medical DERM | 168,618 | 169K direct | $4 | $624K | Jul 1, 2026 |
Is this Miranda Jayne Toledano’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Jul 1, 2026, Miranda Jayne Toledano reported holding 168,618 shares of Journey Medical (DERM). At the last close of $4 on Nov 16, 2026, that is about $624K. This is the stake disclosed in filings, not a net worth.
Miranda Jayne Toledano bought shares on the open market in 2021, 2022 and 2023, and has not bought since 2023 across 2 companies.
In SEC filings since 2021: the latest open-market purchase is from 2023; no open-market sale is on record.
2 companies: Entera Bio (ENTX, 2022–2023), Nexgel (NXGL, 2021).
Miranda Jayne Toledano reported 4 open-market purchases and 0 sales here, 2022 to 2023.
Miranda Jayne Toledano reported 1 open-market purchase and 0 sales here, 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.